glaucoma – media

Aerie Extends Drug-Delivery Tech Contract with DSM Biomedical

The extended deal with DSM offers Aerie an elite worldwide license to DSM’s polyesteramide polymer technology for a limitless number of drugs in any ophthalmic indication and also an exposure to DSM’s preclinical latanoprost implant created for people with glaucoma. The two companies have spanned their partnership till the end of 2020, as per Aerie.
- Source: DrugDeliveryBusiness
- 1,026
- August 3, 2018
Company Insight digital health glaucoma pharmaceutical
Curcumin in Turmeric can Treat Glaucoma

Glaucoma is an eye disorder causing irreversible blindness and affects around 60 million people throughout the world. This condition leads to the loss of retinal ganglion cells, located near the surface of the retina. The prime focus of glaucoma research is to put an end to the loss of these cells in the initial stages.
- Source: MedicalXpress
- 1,271
- July 26, 2018
glaucoma Researches tumeric
Scientists discover potential treatment to stop glaucoma in its tracks

Vision scientists at the University of California, Berkeley, and the University of Toronto have discovered that naturally occurring molecules known as lipid mediators have the potential to halt the progression of glaucoma, the world's second-leading cause of blindness.
- Source: Medicalxpress
- 497
- November 7, 2017
glaucoma lipid mediators neurodegenerative disease

your submission has already been received.

OK

Subscribe

Please enter a valid Email address！

Submit

The most relevant industry news & insight will be sent to you every two weeks.

more

more

Customer Services
Contact Us
Help Center

Buy on Drugdu.com
Browse Product Categories

Free APP

Follow Us

Terms & Conditions | Privacy Policy

粤ICP备16008861号

Copyright © 2016-2018 Drugdu.com. All Rights Reserved.